adebrelimab
Showing 1 - 9 of 9
Cervical Cancer Trial (Adebrelimab)
Not yet recruiting
- Cervical Cancer
- Adebrelimab
- (no location specified)
Nov 28, 2023
Neuroendocrine Carcinoma of the Bladder, Bladder Cancer Trial (Adebrelimab, Etoposide, Cisplatin)
Not yet recruiting
- Neuroendocrine Carcinoma of the Bladder
- Bladder Cancer
- Adebrelimab
- +3 more
- (no location specified)
Oct 14, 2023
Breast Cancer Trial in Wuhan (Adebrelimab, dalpiciclib)
Recruiting
- Breast Cancer
- Adebrelimab
- dalpiciclib
-
Wuhan, Hubei, ChinaTongji Hospital Affiliated of Tongji Medical College Huazhong Un
Nov 20, 2023
Advanced Solid Tumor Trial (Adebrelimab, SHR-1802, Carboplatin/Cisplatin)
Not yet recruiting
- Advanced Solid Tumor
- Adebrelimab
- +3 more
- (no location specified)
Mar 20, 2023
Advanced Solid Tumors Trial in Shanghai (HRXG-K-1939, Adebrelimab)
Not yet recruiting
- Advanced Solid Tumors
- HRXG-K-1939
- Adebrelimab
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 4, 2023
Ovarian Tumors, Ovarian Diseases Trial (Adebrelimab, Fuzuloparib)
Not yet recruiting
- Ovarian Neoplasms
- Ovarian Diseases
- Adebrelimab
- Fuzuloparib
- (no location specified)
Feb 23, 2023
Hepatocellular Carcinoma Trial in Tianjin (HAIC, Adebrelimab, Bevacizumab)
Not yet recruiting
- Hepatocellular Carcinoma
- HAIC
- +2 more
-
Tianjin, Tianjin, ChinaTianjin Cancer Hospital Airport Hospital
Jul 27, 2023
Pancreatic Cancer Trial in Shanghai (Adebrelimab, mRNA tumor vaccines)
Not yet recruiting
- Pancreatic Cancer
- Adebrelimab
- mRNA tumor vaccines
-
Shanghai, Shanghai, ChinaDepartment of Pancreatic Surgery, Fudan University Shanghai Canc
Dec 4, 2023
Advanced Hepatocellular Carcinoma Trial (Adebrelimab, Bevacizumab, SHR-8068)
Not yet recruiting
- Advanced Hepatocellular Carcinoma
- Adebrelimab
- +2 more
- (no location specified)
Jun 30, 2022